Peptide
Pinealon
SaveA Khavinson bioregulator tripeptide (Glu-Asp-Arg) targeted at pineal gland function and central nervous system regulation.
Quick verdict
Part of the Khavinson peptide series. Evidence limited to Russian publications without international replication.
Evidence score
12/ 100
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Russian-language studies from the Khavinson group claim neuroprotective and sleep-regulatory effects. No independent validation.
Benefits
- Claimed CNS and pineal gland support in Russian literature
- Oral bioregulator format
Dosage notes
Russian protocols: 5–10 mg/day orally for 10–30 day courses.
Side effects
- Not well characterized
- Drowsiness possible
Who should be cautious
Not approved outside Russia. Product authenticity from commercial sources is unverified.
What this page cannot tell you
All data from a single research group. Claims are not independently replicated.
Leaderboard scores
- Sleep15
- Mood12
Write a review
Sign in to write a review.